MENLO PARK, Calif., September 4, 2013 - Geron Corporation (GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at 9:45 a.m. Eastern Time on Wednesday, September 11, at the Stifel Nicolaus 2013 Healthcare Conference in Boston.
A live webcast of the presentation will be available at http://www.veracast.com/webcasts/stifel/healthcare2013/69104361814.cfm. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
Anna Krassowska, Ph.D.
Investor and Media Relations
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Geron Corp. via Thomson Reuters ONE